Pulmonary Tuberculosis: Symptoms, Signs, and Chest X-Ray Findings

Pulmonary tuberculosis — TB confined to the lungs — is the most common and most contagious form of tuberculosis, accounting for roughly 80% of all active TB cases worldwide. It is driven by Mycobacterium tuberculosis bacilli lodged in the lung's air spaces, where they trigger a slow-burning immune battle that can smolder silently for months before producing recognizable symptoms. Understanding its cardinal signs — a persistent productive cough, blood-streaked sputum, fever, night sweats, and unintentional weight loss — together with its hallmark chest X-ray patterns is the essential first step toward early diagnosis and treatment.

Table of Contents

  1. Pathophysiology of Lung Cavitation
  2. The Productive Cough Timeline
  3. Hemoptysis: Blood in the Sputum
  4. Constitutional Symptoms — Fever, Night Sweats, Weight Loss
  5. Physical Examination Findings
  6. Chest X-Ray Hallmarks of Pulmonary TB
  7. Sputum Smear Positivity and Transmission Risk
  8. Transmission Risk and Infection Control
  9. Research Papers
  10. Connections
  11. Featured Videos

Pathophysiology of Lung Cavitation

To understand TB's symptoms, it helps to understand what the bacterium is doing inside the lung. Mycobacterium tuberculosis is an extraordinarily successful intracellular pathogen — it survives not despite being swallowed by the immune system's macrophages, but because of it. When a macrophage engulfs a TB bacillus, the bacterium blocks the normal process by which the immune cell destroys its contents. It prevents the phagosome (the internal pouch containing the bacterium) from fusing with the lysosome (the cell's acid-filled digestive bag), effectively hiding in a protected intracellular compartment and quietly multiplying.

The immune system responds by walling off the infected macrophages into a structured barrier called a granuloma — a tight cluster of immune cells (macrophages, T-lymphocytes, B-lymphocytes) that forms a physical boundary around the infection. Granulomas preferentially form in the apex (top) of the lungs, and this location is not random. The lung apex has the highest oxygen tension in the body — the richest oxygen environment — which M. tuberculosis exploits because it is an obligate aerobe that thrives in high-oxygen environments. This is why almost all reactivation TB begins in the upper lobes.

Over time, the center of the granuloma undergoes caseation necrosis — "caseous" is derived from the Latin for cheese (caseus), because the dead tissue in the center of the granuloma turns soft, white, and cheese-like. This caseation is a double-edged sword: it does kill many bacilli, but the TB bacteria that survive inside the caseous material can persist in a dormant state for years. In some people, particularly those who are immunocompromised, malnourished, or under physiological stress, the immune balance tips, and the caseous material begins to liquefy. This liquefied necrotic material eventually erodes through the wall of a nearby bronchus (airway), drains into the airways, and is coughed up — creating a cavity.

A TB cavity is essentially a bacterial amplifier. The liquefied caseous material contains 10 million to 1 billion (M. tuberculosis) bacilli per milliliter — an enormous bacterial burden. Once open to the airway, this material is continuously aerosolized with each cough, making cavitary pulmonary TB the most infectious form of the disease. The cavity also provides a constant reservoir that resists antibiotic penetration, which is one reason why TB requires months of multi-drug treatment even when the bacteria appear susceptible on laboratory testing.

Back to Table of Contents

The Productive Cough Timeline

The cough of pulmonary tuberculosis has a characteristic timeline that distinguishes it from more common respiratory infections — but only if someone is paying attention over weeks rather than days. In the early phase, the cough is dry and nonproductive: the bronchial mucosa is irritated by inflammation but there is not yet significant secretion or necrotic material entering the airways. Many patients dismiss this as a "chest cold" or smoker's cough, and without a reason to suspect TB, clinicians often do the same.

Over two to eight weeks, the cough typically becomes productive — patients begin raising sputum that is initially whitish or slightly yellow (mucopurulent), reflecting neutrophil and macrophage-rich secretions from the inflamed lung. As cavitation progresses, sputum can become more copious and may develop a foul odor if secondary bacterial infection takes hold. The quantity of sputum can be striking in advanced disease — some patients produce several tablespoons per day.

Many patients notice the cough is worst in the morning. This pattern has a straightforward explanation: during sleep, secretions and liquefied material accumulate in the airways and cavities; on waking and moving upright, this accumulated material drains into larger airways and triggers a burst of productive coughing. The same morning-dominant pattern is seen in other suppurative lung conditions like bronchiectasis, and its presence should prompt inquiry about chronic respiratory illness.

Public health guidelines worldwide use the "3-week rule": any cough lasting more than three weeks in a person from or living in an area with significant TB burden warrants sputum testing for TB, even before other symptoms are present. This threshold reflects the biology of early TB — a cough present for three weeks is unlikely to be a self-resolving viral illness and demands further investigation. Unfortunately, the average delay from symptom onset to TB diagnosis in high-burden countries remains two to three months, during which time an untreated smear-positive patient may infect 10 to 15 contacts.

Back to Table of Contents

Hemoptysis: Blood in the Sputum

Hemoptysis — coughing up blood — ranges from a barely visible blood streak in sputum to a medical emergency involving frank hemorrhage, and TB is one of the most important causes of each presentation. The source and mechanism differ significantly depending on the stage of disease.

In early or mild hemoptysis, patients notice blood-streaked mucus — thin red or rust-colored threads running through otherwise normal sputum. This reflects minor erosion of small mucosal vessels by the inflammatory process, and while alarming to the patient, it does not usually indicate immediate danger. It is, however, a critical diagnostic signal: blood-streaked sputum in anyone with a persistent cough and constitutional symptoms should trigger immediate TB evaluation.

In cavitary disease, more significant hemoptysis can occur when the expanding cavity erodes into a pulmonary artery branch. Over time, the vessel wall weakens, forming a Rasmussen aneurysm — a pseudoaneurysm (false aneurysm) of a pulmonary artery branch within the cavity wall, named after the 19th-century Danish physician Niels Rasmussen. Rupture of a Rasmussen aneurysm produces massive hemoptysis — defined as more than 200–600 mL of blood per 24 hours depending on which definition is used — and is potentially fatal, primarily through asphyxiation rather than exsanguination. The airways fill with blood faster than the patient can clear it. Massive hemoptysis from TB is a true medical emergency requiring immediate airway protection and specialist intervention.

A late complication worth understanding is aspergilloma — a fungal ball formed by Aspergillus species colonizing an old, healed TB cavity. Aspergillus spores inhaled from the environment settle into the empty cavity and grow into a matted ball of fungal hyphae, mucus, and debris. Aspergilloma itself is not a TB reactivation, but it causes its own hemoptysis by eroding cavity vessels or by the mechanical irritation of the fungal ball against the cavity wall. In areas where TB is common, aspergilloma is a recognized sequela in patients with a history of treated TB who develop new or recurrent hemoptysis years later.

Back to Table of Contents

Constitutional Symptoms — Fever, Night Sweats, Weight Loss

The three constitutional symptoms of tuberculosis — fever, drenching night sweats, and significant weight loss — together formed the clinical picture that gave TB its most famous historical name: consumption. Patients were said to be "consumed" by the disease, visibly wasting away over months. Understanding the mechanism behind each symptom explains both why they occur and why they follow the characteristic pattern TB clinicians learn to recognize.

Fever in TB is driven by the host immune response to bacterial cell wall components, particularly lipoarabinomannan (LAM) and other mycobacterial antigens, which trigger macrophages to release pro-inflammatory cytokines — primarily tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6). These cytokines act on the hypothalamic thermostat (the preoptic area) to reset the body's temperature set-point upward. What distinguishes TB fever from the fever of an acute bacterial infection is its character: it is typically low-grade (37.5–38.5°C or 99.5–101.3°F), often afternoon-dominant (rising in the late afternoon and evening), and persistent over weeks to months rather than peaking and resolving. Afternoon fever in a chronically unwell patient should always raise TB on the differential diagnosis.

Night sweats are, in effect, the fever's resolution. During the night, the same cytokine-driven thermostat reset that elevated body temperature during the day begins to normalize. To lose the excess heat rapidly, the hypothalamus triggers profuse sweating — the body's primary cooling mechanism. Patients describe waking to find their pajamas and sheets saturated with sweat despite normal room temperature. The night sweats of TB are classically described as drenching, requiring a change of clothes and bedding, to distinguish them from the mild perspiration many people experience normally.

Weight loss in TB is multi-factorial. TNF-α (historically called cachexin before its identity was known) suppresses appetite and increases basal metabolic rate, creating a state of accelerated catabolism even when food intake is maintained. The ongoing immune battle consumes enormous energy. Poor appetite from systemic illness, nausea from medications, and (in resource-limited settings) food insecurity compound the metabolic loss. The typical trajectory in untreated TB is a slow, progressive loss of lean muscle mass and fat stores over months — more than 10% of baseline body weight is a significant clinical threshold. In pre-antibiotic era patients, the terminal phase of untreated TB could reduce a previously healthy adult to skeletal appearance within 12–18 months.

Back to Table of Contents

Physical Examination Findings

While the stethoscope and the examiner's hands cannot diagnose TB, a careful physical examination can provide important clues that support the suspicion — and in resource-limited settings where imaging and laboratory access are delayed, these findings may be the most immediately available evidence.

Percussion dullness at the lung apices is an important finding. Normally, the air-filled lung produces a resonant, drum-like sound on percussion. When the upper lobe is consolidated (filled with inflammatory exudate or caseous material) or replaced by fibrosis from healed TB, the percussion note becomes dull — the same flat sound heard over solid tissue. Apical dullness, particularly in the posterior upper zones, is a classic sign of advanced TB in the upper lobes.

Post-tussive apical crackles are perhaps the most specific auscultatory sign of pulmonary TB. The technique requires asking the patient to cough once, then immediately listening over the lung apex with the stethoscope. Coughing briefly opens small airways and loosens secretions; in a TB-affected apex, fine crackles can be heard in the seconds immediately following the cough that would not be audible during quiet breathing. These post-tussive rales reflect the mucus-filled or fluid-filled small airways in the inflamed apical zone.

Amphoric (cavernous) breath sounds are heard over large cavities. When air moves in and out of a cavity connected to a bronchus, the sound produced is hollow and echoing — clinicians describe it as similar to blowing across the mouth of a glass bottle (Greek amphora = large jar). This distinctive sound, combined with percussion dullness and post-tussive crackles in the same region, is highly suggestive of cavitary lung disease.

Decreased or absent breath sounds at a lung base suggest a pleural effusion — fluid accumulating between the lung and chest wall. TB pleuritis (pleural TB) can occur alongside pulmonary TB and produces a unilateral effusion. The fluid compresses the adjacent lung, reducing breath sounds in that region. Tuberculous pleural effusions are typically exudative (protein-rich), lymphocyte-predominant on pleural fluid analysis, and ADA (adenosine deaminase) elevated.

Cervical lymphadenopathy — enlarged lymph nodes in the neck — is common in TB, particularly in younger patients and those from high-prevalence regions. The nodes are classically described as matted (nodes fused together by periadenitis) and may become fluctuant (soft and fluid-filled) if caseation and liquefaction occur within the node — this is scrofula, historically one of the most visible manifestations of TB.

Digital clubbing (bulbous enlargement of fingertips with loss of the normal nail-bed angle) develops in some patients with chronic suppurative pulmonary disease, including long-standing or complicated TB. It reflects chronic hypoxia and local growth factor signaling from the diseased lung. Cachexia — visible muscle wasting, prominent bones, and loss of subcutaneous fat — is apparent in advanced untreated cases and was the defining physical image of tuberculosis in the 18th and 19th centuries.

Back to Table of Contents

Chest X-Ray Hallmarks of Pulmonary TB

The chest X-ray remains the most widely available and practically useful initial imaging tool for pulmonary TB. While it cannot confirm a TB diagnosis (only microbiological or molecular methods can), specific radiographic patterns are strongly suggestive and should prompt immediate further evaluation. Crucially, a normal chest X-ray does not exclude TB — particularly in early disease or in patients with HIV.

Primary TB pattern (seen mainly in children and newly infected immunocompromised adults): the initial infection tends to occur in the lower or middle zones of the lung where inhaled particles preferentially land. The X-ray may show a parenchymal consolidation (an area of hazy opacity where air spaces are filled) in the mid or lower zone, combined with hilar lymphadenopathy (enlarged lymph nodes at the root of the lung, visible as a widening of the hilum on the X-ray). This combination of a peripheral consolidation with hilar adenopathy is called the primary or Ghon complex. In most immunocompetent children and adults, primary TB is controlled, the consolidation resolves, and the Ghon focus (the site of initial infection) calcifies over years into a small, dense, radio-opaque scar visible on later X-rays.

Post-primary (reactivation) TB pattern (most common pattern in adults): reactivation of latent TB — either the patient's own old primary infection or a new superinfection — occurs almost exclusively in the upper lobes, particularly in the posterior segment of the upper lobe and the superior segment of the lower lobe (the segments with the highest oxygen tension). On the chest X-ray, this appears as patchy or nodular infiltrates — areas of increased opacity (whiteness) — in one or both upper zones. The infiltrates may be unilateral or bilateral, and their location in the posterior upper zones is the single most characteristic radiographic feature of reactivation TB.

Cavity: when caseation liquefies and drains into a bronchus, the resulting airspace within the consolidation appears on X-ray as a lucency (dark area representing air) within the dense opacity, often with a visible thick wall. This is the radiographic cavity — pathognomonic of advanced, active pulmonary TB. Cavities confirm high bacterial burden and high infectivity. Multiple cavities in both upper lobes suggest long-standing uncontrolled disease.

Miliary TB pattern: when the bacteremia (bacteria entering the bloodstream) overwhelms local containment, M. tuberculosis seeds the entire lung through the bloodstream, producing thousands of tiny discrete nodules measuring 1–2 mm scattered evenly throughout both lungs. On X-ray, this appears as a "snow-storm" or fine sandy pattern of innumerable tiny nodules throughout both lung fields. The name "miliary" comes from the Latin milium (millet seed), because the lung nodules resemble millet seeds in size and distribution. Miliary TB is a life-threatening emergency and is most common in immunocompromised patients, young children, and the elderly.

Pleural effusion appears as opacification of one hemithorax, typically denser at the base with a curved upper border (meniscus sign). Tuberculous effusions can be large, occupying half or more of the hemithorax and causing mediastinal shift toward the opposite side.

Bronchiectasis — permanent dilation of airways — can result from healed TB that damaged the bronchial walls. On chest X-ray, this may appear as parallel "tram-track" lines (dilated airway walls viewed end-on) or ring shadows; it is better demonstrated on CT. Healed TB also leaves linear fibrotic scarring, volume loss in the upper lobes, and calcified nodules or lymph nodes.

A critically important point: in patients co-infected with HIV, especially those with advanced immunodeficiency (low CD4 counts), chest X-ray findings are frequently atypical. Upper-lobe involvement may be absent; lower-zone infiltrates, hilar adenopathy, and even a normal-appearing X-ray are more common. This is because the typical TB radiographic pattern depends on a CD4+ T-cell-mediated immune response to form granulomas and control the bacteria in the upper lobes — without adequate CD4 cells, the immune geography of TB changes completely.

Back to Table of Contents

Sputum Smear Positivity and Transmission Risk

Sputum smear microscopy is the fastest and most widely available laboratory test for pulmonary TB: a sputum sample is smeared on a glass slide and stained using the Ziehl-Neelsen (ZN) stain. Mycobacteria have a waxy, lipid-rich cell wall that resists decolorization with acid-alcohol after staining with carbolfuchsin — they are therefore called "acid-fast bacilli" (AFB). The red bacilli appear against a blue background under the microscope.

Smear results are graded semi-quantitatively based on how many AFB are seen per microscopic field: a 3+ smear-positive result (more than 10 AFB per field) indicates an enormous bacterial burden in the sputum and correlates with high infectivity, cavitary disease on X-ray, and a higher secondary attack rate among contacts. A 1+ result (1–9 AFB per 100 fields) still confirms the diagnosis and carries transmission risk, though lower. Smear microscopy has a sensitivity of roughly 45–80% for culture-positive TB — meaning up to half of true TB cases may be smear-negative.

Smear-negative pulmonary TB (sputum culture positive but ZN smear negative) is still infectious and should be treated promptly, though the transmission risk per contact-hour is substantially lower than for smear-positive disease. WHO guidelines define smear-negative TB as a distinct diagnostic category requiring at least two smear-negative sputum specimens, a chest X-ray consistent with TB, and either a positive culture or clinical response to TB treatment.

One of the most clinically important facts for patients and families to understand is how quickly treatment reduces infectivity. Within two to three weeks of starting effective multi-drug TB treatment, smear positivity typically falls dramatically in drug-susceptible TB. The patient may still be smear-positive on a slide, but the surviving bacteria are often non-viable or present in far lower numbers. Most infection control guidelines require three consecutive negative sputum smears collected on different days before a hospitalized TB patient can be de-isolated and moved to a non-negative-pressure room.

The physics of TB transmission are worth understanding. TB is spread through airborne droplet nuclei — tiny particles (1–5 micrometers in diameter) produced when a person with pulmonary TB coughs, sneezes, sings, or talks. These particles are small enough to remain suspended in room air for hours. Larger droplets (produced by a cough or sneeze) fall quickly to the ground and are less important for transmission. Standard surgical masks do not reliably filter particles this small; N95 respirators (which filter at least 95% of 0.3-micron particles) provide meaningful protection for healthcare workers and close contacts in enclosed spaces.

Back to Table of Contents

Transmission Risk and Infection Control

The epidemiology of TB transmission is understood through the Wells-Riley model, which describes the probability of infection as a function of the rate at which infectious particles (called "quanta" of infection) are generated by an infectious source, the ventilation rate of the room, the duration of exposure, and the breathing rate of exposed individuals. This model — developed by epidemiologist William Firth Wells in the 1950s and refined by Richard Riley — mathematically explains why TB spreads so effectively in crowded, poorly ventilated spaces and so poorly in open outdoor environments.

The key factors that increase transmission risk are: high smear grade (more bacteria per cough), cavitary disease (higher bacterial production), frequent coughing (more aerosol generated), prolonged exposure duration, small enclosed space with poor air exchange, and a susceptible contact (immunocompromised, young, never previously infected). Conversely, outdoors, transmission risk drops to near zero because dilution of airborne particles by ambient air makes meaningful exposure extremely unlikely.

Among household contacts of a smear-positive pulmonary TB case, approximately 30% will become infected (develop a positive tuberculin skin test or IGRA, indicating immune sensitization) with sustained exposure over weeks to months. Of those infected, roughly 5–10% will develop active TB disease within the first two years, and another 5% over their remaining lifetime. This latent-to-active conversion risk is dramatically higher in immunocompromised individuals: a person co-infected with HIV and TB has a 7–10% annual risk of progressing from latent to active TB (compared to ~0.1% per year in an immunocompetent person).

In healthcare settings, TB poses a recognized occupational hazard, particularly for workers who perform aerosol-generating procedures such as bronchoscopy, sputum induction, intubation, or administration of nebulized medications to a TB patient. These procedures dramatically increase the concentration of infectious particles in the immediate environment. N95 respirators, negative-pressure isolation rooms (where air is exhausted to the outside and not recirculated to other areas), and careful protocols for aerosol-generating procedures are the cornerstones of healthcare infection control.

Ultraviolet germicidal irradiation (UVGI) — UV-C light at 254 nm wavelength — is highly effective at inactivating airborne M. tuberculosis and has been used in clinical settings, waiting rooms, and congregate shelters to reduce transmission. Upper-room UVGI (fixtures mounted high on walls irradiating the upper air zone while protecting occupants below) is a proven adjunct to ventilation in high-risk environments. HEPA (high-efficiency particulate air) filtration in recirculating air systems can also capture TB-sized particles, but proper maintenance and adequate air exchanges per hour are essential for effectiveness.

The de-isolation criteria for a hospitalized TB patient — the point at which transmission risk is considered sufficiently low to end airborne precautions — require clinical improvement, at least two weeks of effective therapy, and three consecutive sputum smears negative for AFB, each collected at least 8 hours apart and including at least one early-morning specimen. A patient who remains highly symptomatic or who has drug-resistant TB may require a longer period of isolation regardless of smear results, as clinical judgment must supplement laboratory criteria.

Back to Table of Contents

Research Papers

  1. Furin et al., NEJM 2019 (PMID 31454893) — Comprehensive review of tuberculosis covering pathogenesis, epidemiology, diagnosis, and treatment, providing an authoritative clinical overview for practitioners.
  2. Dannenberg AM Jr., 1997 (PMID 9708836) — Classic pathogenesis review detailing how M. tuberculosis survives inside macrophages, granuloma biology, and the mechanisms of caseation necrosis and cavity formation.
  3. Pai et al., Nat Rev Dis Primers 2016 (PMID 29386178) — Definitive primer on tuberculosis covering the spectrum from latent infection to active pulmonary disease, with detailed review of diagnostic approaches and global burden.
  4. Dye C and Scheele S, 2005 (PMID 15608701) — Global TB epidemiology analysis quantifying the annual risk of infection and explaining how smear-positive cases drive the transmission cycle in high-burden settings.
  5. Barnes PF, 1994 (PMID 7695836) — Foundational review of tuberculosis radiology describing the primary and post-primary X-ray patterns, cavitation, miliary disease, and the atypical presentations seen in immunocompromised patients.
  6. MacGregor RR, 1993 (PMID 2684237) — Analysis of alcohol use as a major risk factor for TB, explaining the immune mechanisms by which chronic alcohol impairs macrophage function and granuloma formation, increasing progression from latent to active disease.
  7. Menzies et al., CMAJ 2014 (PMID 25230299) — Canadian guidelines review covering diagnosis, risk stratification, and management of tuberculosis including smear interpretation and de-isolation criteria for hospitalized patients.
  8. Dorman et al., Lancet (PMID 26707842) — Major clinical trial evaluating treatment regimens for drug-susceptible pulmonary TB, with data on bacteriological conversion rates and their correlation with smear positivity grades.
  9. Zumla et al., Lancet 2013 (PMID 22080557) — Advances in TB review covering improved understanding of TB transmission, newer diagnostic technologies, and emerging treatment strategies, with discussion of airborne infection control.
  10. Saukkonen et al., AJRCCM 2010 (PMID 19875218) — ATS statement on hepatotoxicity from anti-tuberculosis treatment, relevant to understanding the monitoring requirements and adverse effect burden patients face during the standard multi-drug regimen.

Back to Table of Contents

Connections

Back to Table of Contents